21384-42-9 Usage
Description
(2-methylaziridin-1-yl)(2-methylphenyl)methanone, also known as mitobronitol, is a chemical compound belonging to the aziridine class, which is known for its alkylating properties. Mitobronitol possesses potential medicinal properties and has been studied for its anti-cancer effects, particularly in the treatment of brain tumors and other solid tumors. Its mechanism of action involves interfering with the replication and transcription of DNA, leading to cell death in cancer cells.
Uses
Used in Pharmaceutical Industry:
Mitobronitol is used as an anti-cancer agent for its potential therapeutic effects against brain tumors and other solid tumors. Its alkylating properties enable it to interfere with the replication and transcription of DNA in cancer cells, resulting in cell death and potentially leading to tumor reduction.
Used in Cancer Research:
Mitobronitol is utilized in cancer research as a subject of study for its potential applications in developing new and more effective treatments for various types of cancer. Ongoing research aims to explore the compound's properties and mechanisms, as well as to develop derivatives that may offer improved efficacy and reduced side effects in cancer therapy.
Check Digit Verification of cas no
The CAS Registry Mumber 21384-42-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,3,8 and 4 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 21384-42:
(7*2)+(6*1)+(5*3)+(4*8)+(3*4)+(2*4)+(1*2)=89
89 % 10 = 9
So 21384-42-9 is a valid CAS Registry Number.
21384-42-9Relevant articles and documents
Synthesis and biological activities of 4-phenyl-5-pyridyl-1,3-thiazole derivatives as selective adenosine A3 antagonists
Miwatashi, Seiji,Arikawa, Yasuyoshi,Matsumoto, Tatsumi,Uga, Keiko,Kanzaki, Naoyuki,Imai, Yumi N.,Ohkawa, Shigenori
experimental part, p. 1126 - 1137 (2009/09/25)
To investigate the potency of an adenosine A3 receptor (A 3AR) antagonist as an anti-asthmatic drug, a novel series of 4-phenyl-5-pyridyl-1,3-thiazole derivatives was synthesized and evaluated in human adenosine A1, A
Adenosine A3 receptor antagonists
-
, (2008/06/13)
A pharmaceutical composition for antagonizing adenosine at adenosine A3receptors which comprises a 1,3-azole compound substituted on the 4- or 5-position, or both, by a pyridyl which may be substituted is provided and can be used as a prophylactic and therapeutic agent for asthma, allergosis, inflammation, and so on.
